Systemic Lupus Erythematosus (SLE) with Acute Nephritis, Antineutrophil Cytoplasmic Antibody- (ANCA-) Associated Vasculitis, and Thrombotic Thrombocytopenic Purpura (TTP): A Rare Case Report with Literature Review

Table 4

TTP and SLE treatments and outcomes.

Author	Age	Treatment	Outcome
Changcharoen and Bolger [4]	35 years	Plasma exchange; Glucocorticoids; Hydroxychloroquine; Mycophenolate	Resolution of acute symptoms; Clinical and laboratory findings back to baseline; Clinical remission achieved
Bamidele et al. [5]	58 years	Glucocorticoids; Hydroxychloroquine	Resolution of TTP specific acute symptoms; Lupus exacerbation; Clinical remission status unknown
Abu-Hismeh et al. [10]	34 years	Plasma exchange; Glucocorticoids; Rituximab; Cyclophosphamide	Unresponsive to plasma exchange, glucocorticoids, and rituximab; After cyclophosphamide, achieved clinical and laboratory findings back to baseline; Clinical remission achieved
Blum and Blake [11]	44 years	Plasma exchange; Glucocorticoids; Mycophenolate; Cyclophosphamide	Hemolytic parameters nearly or completely normalized; Active inflammation markers decreased; Remained dependent on dialysis; Clinical remission achieved